Vaxcyte, Inc. (PCVX)
USD 85.75
(-4.57%)
USD 85.75
(-4.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -296.79 Million | -170.59 Million | -121.39 Million | -46.62 Million | -47.14 Million | -30.46 Million |
| Net Income | -402.26 Million | -223.48 Million | -100.07 Million | -89.21 Million | -50.27 Million | -29.48 Million |
| Depreciation & Amortization | 10.17 Million | 9.19 Million | 3.45 Million | 1.4 Million | 1.23 Million | 1.03 Million |
| Deferred income taxes | -11.22 Million | - | - | 301 Thousand | 1000.00 | 51 Thousand |
| Stock-based compensation | 48.76 Million | 23.65 Million | 10.72 Million | 5.43 Million | 1.18 Million | 749 Thousand |
| Change in working capital | 81.32 Million | 12.73 Million | -37 Million | 35.27 Million | 3.9 Million | 1.89 Million |
| Other non-cash items | -23.55 Million | 7.3 Million | 1.5 Million | 179 Thousand | -3.19 Million | -4.71 Million |
| Investing Cash Flow | -773.31 Million | 74.58 Million | -212.3 Million | -1.1 Million | -1.19 Million | -1.77 Million |
| Investments in PPE | -67.87 Million | -5.84 Million | -6.55 Million | -1.15 Million | -1.19 Million | -1.77 Million |
| Acquisitions | 51.81 Million | 7000.00 | 26 Thousand | 50 Thousand | - | 1000.00 |
| Investment purchases | -1.32 Billion | -102.74 Million | -336.34 Million | - | - | - |
| Sales/Maturities of investments | 624.46 Million | 183.17 Million | 130.56 Million | - | - | - |
| Other Investing Activities | -51.81 Million | 80.43 Thousand | -205.75 Thousand | 50.00 | - | 1000.00 |
| Financing Cash Flow | 639.81 Million | 861.54 Million | 17.79 Million | 374.87 Million | 41.56 Million | 62.19 Million |
| Debt repayment | - | - | - | -61 Thousand | -278 Thousand | -283 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 2.03 Million | 1.03 Million | 888 Thousand | 374 Thousand | - | - |
| Common Stock Issuance | 643.68 Million | 856.48 Million | 17.79 Million | 267.37 Million | 42.94 Million | 62.47 Million |
| Other Financing Activities | 3.77 Million | 4.03 Million | 17.79 Thousand | 107.55 Million | -1.09 Million | 62.47 Million |
| Accounts receivables | - | - | - | - | 868 Thousand | 1.26 Million |
| Accounts payables | 11.22 Million | 2.89 Million | -12.47 Million | 26.1 Million | 868 Thousand | 1.26 Million |
| Inventory | - | - | - | - | 2.87 Million | -1.18 Million |
| Other working capital | 70.09 Million | 9.84 Million | -24.53 Million | 9.16 Million | -698 Thousand | 550 Thousand |
| Cash at beginning of period | 834.65 Million | 69.85 Million | 386.2 Million | 58.97 Million | 66.09 Million | 36.13 Million |
| Cash at end of period | 397.45 Million | 835.52 Million | 69.85 Million | 386.2 Million | 58.97 Million | 66.09 Million |
| Capital Expenditure | -67.87 Million | -5.84 Million | -6.55 Million | -1.15 Million | -1.19 Million | -1.77 Million |
| Effect of forex changes on cash | -6.68 Million | 137 Thousand | -439 Thousand | 87 Thousand | -341 Thousand | - |
| Net cash flow / Change in cash | -437.2 Million | 765.67 Million | -316.34 Million | 327.22 Million | -7.11 Million | 29.95 Million |
| Free Cash Flow | -364.66 Million | -176.44 Million | -127.94 Million | -47.78 Million | -48.34 Million | -32.24 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -103.12 Million | -128.7 Million | -95.02 Million | -402.26 Million | -180.8 Million | -92.66 Million |
| Depreciation & Amortization | 4.49 Million | 3.47 Million | 3.09 Million | 10.17 Million | 2.94 Million | 2.48 Million |
| Deferred income taxes | - | - | - | -11.22 Million | -12.76 Million | - |
| Stock-based compensation | 21.26 Million | 21.55 Million | 17.62 Million | 48.76 Million | 13.34 Million | 13.22 Million |
| Change in working capital | 81.62 Million | -7.79 Million | -73.83 Million | 81.32 Million | 38.06 Million | 33.98 Million |
| Other non-cash items | -64.96 Million | -9.93 Million | 7.14 Million | -23.55 Million | 10.39 Million | -14.57 Million |
| Investing Cash Flow | -917.01 Million | -80.4 Million | -451.07 Million | -773.31 Million | -13.92 Million | 22.28 Million |
| Investments in PPE | 39.04 Million | -45.37 Million | -12.07 Million | -67.87 Million | -57.06 Million | -7.33 Million |
| Acquisitions | - | - | - | 51.81 Million | -43.14 Thousand | -29.61 Thousand |
| Investment purchases | -1.23 Billion | -350.64 Million | -687.69 Million | -1.32 Billion | -203.61 Million | -209.67 Million |
| Sales/Maturities of investments | 354.2 Million | 309.22 Million | 248.69 Million | 624.46 Million | 246.75 Million | 239.29 Million |
| Other Investing Activities | -77.12 Million | 6.39 Million | -6.39 Million | -51.81 Million | 43.14 Thousand | 29.61 Thousand |
| Financing Cash Flow | 1.51 Billion | 110.36 Million | 818.19 Million | 639.81 Million | 2.73 Million | 48.55 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 5.52 Million | -565 Thousand | -3.3 Million | 2.03 Million | 3.54 Million | -2.6 Million |
| Common Stock Issuance | -731.44 Million | 110.93 Million | 816.47 Million | 643.68 Million | 3.06 Million | 49 Million |
| Other Financing Activities | 2.24 Billion | 3.83 Million | -3.3 Million | -5.91 Million | -3.87 Million | 2.15 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 8.31 Million | -10.7 Million | 5.67 Million | 11.22 Million | 6.47 Million | 694 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 5.05 Million | 2.91 Million | -7.96 Million | 70.09 Million | 31.58 Million | 33.29 Million |
| Cash at beginning of period | 518.66 Million | 611.51 Million | 398.55 Million | 834.65 Million | 545.13 Million | 531.9 Million |
| Cash at end of period | 1.05 Billion | 518.66 Million | 612.61 Million | 397.45 Million | 397.45 Million | 546.23 Million |
| Capital Expenditure | 39.04 Million | -45.37 Million | -12.07 Million | -67.87 Million | -57.06 Million | -7.33 Million |
| Effect of forex changes on cash | -5.57 Million | -1.41 Million | 6.06 Million | -6.68 Million | -7.68 Million | 1.05 Million |
| Net cash flow / Change in cash | 532.83 Million | -92.84 Million | 214.06 Million | -437.2 Million | -147.68 Million | 14.33 Million |
| Free Cash Flow | -21.66 Million | -166.76 Million | -171.19 Million | -364.66 Million | -185.87 Million | -64.88 Million |
LLY
2451
SBO
LNTO
SMDM
RELT